Access the full text.
Sign up today, get DeepDyve free for 14 days.
V. Waard, I. Bot, S. Jager, Sarah Talib, K. Egashira, M. Vries, P. Quax, E. Biessen, T. Berkel (2010)
Systemic MCP1/CCR2 blockade and leukocyte specific MCP1/CCR2 inhibition affect aortic aneurysm formation differently.Atherosclerosis, 211 1
S. Deshmane, S. Kremlev, S. Amini, B. Sawaya (2009)
Monocyte chemoattractant protein-1 (MCP-1): an overview.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 29 6
A. Kalinowska, J. Losy (2008)
Investigational C-C chemokine receptor 2 antagonists for the treatment of autoimmune diseasesExpert Opinion on Investigational Drugs, 17
C. Shi, Ting Jia, S. Méndez-Ferrer, T. Hohl, N. Serbina, Lauren Lipuma, Ingrid Leiner, Ming Li, P. Frenette, E. Pamer (2011)
Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating toll-like receptor ligands.Immunity, 34 4
Jian Guo, V. Waard, M. Eck, Reeni Hildebrand, E. Wanrooij, J. Kuiper, N. Maeda, G. Benson, P. Groot, T. Berkel (2005)
Repopulation of Apolipoprotein E Knockout Mice With CCR2-Deficient Bone Marrow Progenitor Cells Does Not Inhibit Ongoing Atherosclerotic Lesion DevelopmentArteriosclerosis, Thrombosis, and Vascular Biology, 25
R. Wirka, R. Wirka, D. Wagh, D. Paik, D. Paik, M. Pjanić, M. Pjanić, Trieu Nguyen, Trieu Nguyen, Clint Miller, R. Kundu, R. Kundu, Manabu Nagao, Manabu Nagao, J. Coller, Tiffany Koyano, R. Fong, Y. Woo, Boxiang Liu, S. Montgomery, Joe Wu, Joseph Wu, Kuixi Zhu, Rui Chang, Melissa Alamprese, M. Tallquist, J. Kim, J. Kim, T. Quertermous, T. Quertermous (2019)
Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysisNature medicine, 25
Carla Winter, C. Silvestre-Roig, A. Ortega-Gómez, Patricia Lemnitzer, H. Poelman, Ariane Schumski, Janine Winter, Maik Drechsler, R. Jong, R. Immler, M. Sperandio, Michael Hristov, T. Zeller, G. Nicolaes, C. Weber, Joana Viola, A. Hidalgo, C. Scheiermann, O. Soehnlein (2018)
Chrono-pharmacological Targeting of the CCL2-CCR2 Axis Ameliorates Atherosclerosis.Cell metabolism, 28 1
Sherri Moore, Vivian Holt, Lillie Malpass, Ian Hines, M. Wheeler (2015)
Fatty acid-binding protein 5 limits the anti-inflammatory response in murine macrophages.Molecular immunology, 67 2 Pt B
Karishma Rahman, Y. Vengrenyuk, S. Ramsey, Noemi Vila, N. Girgis, Jianhua Liu, V. Gusarova, J. Gromada, Ada Weinstock, K. Moore, P. Loke, E. Fisher (2017)
Inflammatory Ly6Chi monocytes and their conversion to M2 macrophages drive atherosclerosis regressionJournal of Clinical Investigation, 127
R. Hartman, K. Owsiany, Lijiang Ma, Simon Koplev, K. Hao, L. Slenders, M. Civelek, M. Mokry, J. Kovacic, G. Pasterkamp, G. Owens, J. Björkegren, H. Ruijter (2021)
Sex-Stratified Gene Regulatory Networks Reveal Female Key-Driver Genes of Atherosclerosis Involved in Smooth Muscle Cell Phenotype Switching.Circulation
Valerie Wall, Shelley Barnhart, Jenny Kanter, Farah Kramer, Masami Shimizu-Albergine, N. Adhikari, T. Wight, Jennifer Hall, K. Bornfeldt (2018)
Smooth muscle glucose metabolism promotes monocyte recruitment and atherosclerosis in a mouse model of metabolic syndrome.JCI insight, 3 11
LS Shankman, D Gomez, OA Cherepanova, M Salmon, GF Alencar, RM Haskins, P Swiatlowska, AA Newman, ES Greene, AC Straub (2015)
KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis., 21
Matthew Neal, A. Boyle, Kevin Budge, F. Safadi, J. Richardson (2018)
The glycoprotein GPNMB attenuates astrocyte inflammatory responses through the CD44 receptorJournal of Neuroinflammation, 15
L. Boring, J. Gosling, Michael Cleary, I. Charo (1998)
Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosisNature, 394
B. Lu, B. Rutledge, L. Gu, J. Fiorillo, N. Lukacs, S. Kunkel, R. North, C. Gerard, B. Rollins (1998)
Abnormalities in Monocyte Recruitment and Cytokine Expression in Monocyte Chemoattractant Protein 1–deficient MiceThe Journal of Experimental Medicine, 187
Young Park (2014)
CD36, a scavenger receptor implicated in atherosclerosisExperimental & Molecular Medicine, 46
Z. Szekanecz, A. Koch (2016)
Successes and failures of chemokine-pathway targeting in rheumatoid arthritisNature Reviews Rheumatology, 12
I. Bot, Natalia Zacarías, W. Witte, H. Vries, P. Santbrink, D. Velden, M. Kröner, Dirk-Jan Berg, Dean Stamos, E. Lange, J. Kuiper, A. IJzerman, L. Heitman (2017)
A novel CCR2 antagonist inhibits atherogenesis in apoE deficient mice by achieving high receptor occupancyScientific Reports, 7
X. Yu, S. Dluz, D. Graves, L. Zhang, H. Antoniades, W. Hollander, S. Prusty, A. Valente, C. Schwartz, G. Sonenshein (1992)
Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates.Proceedings of the National Academy of Sciences of the United States of America, 89 15
Y. Miyabe, J. Lian, C. Miyabe, A. Luster (2019)
Chemokines in rheumatic diseases: pathogenic role and therapeutic implicationsNature Reviews Rheumatology
S. Mahler, T. Register, Robert Riley, R. D'Agostino, J. Stopyra, Chadwick Miller (2018)
Monocyte Chemoattractant Protein-1 as a Predictor of Coronary Atherosclerosis in Patients Receiving Coronary AngiographyCritical Pathways in Cardiology, 17
S. Allahverdian, Ali Chehroudi, B. McManus, T. Abraham, G. Francis (2014)
Contribution of Intimal Smooth Muscle Cells to Cholesterol Accumulation and Macrophage-Like Cells in Human AtherosclerosisCirculation, 129
S. Feil, B. Fehrenbacher, R. Lukowski, F. Essmann, K. Schulze-Osthoff, M. Schaller, R. Feil (2014)
Transdifferentiation of Vascular Smooth Muscle Cells to Macrophage-Like Cells During AtherogenesisCirculation Research, 115
C. Combadière, Stephane Potteaux, M. Rodero, T. Simon, A. Pézard, B. Esposito, R. Merval, A. Proudfoot, A. Tedgui, Z. Mallat (2008)
Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6Chi and Ly6Clo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic MiceCirculation, 117
D. Chistiakov, A. Melnichenko, V. Myasoedova, A. Grechko, A. Orekhov (2017)
Mechanisms of foam cell formation in atherosclerosisJournal of Molecular Medicine, 95
P. Duewell, H. Kono, K. Rayner, C. Sirois, G. Vladimer, F. Bauernfeind, G. Abela, L. Franchi, G. Núñez, M. Schnurr, T. Espevik, E. Lien, K. Fitzgerald, K. Rock, K. Moore, S. Wright, V. Hornung, E. Latz (2010)
NLRP3 inflamasomes are required for atherogenesis and activated by cholesterol crystals that form early in diseaseNature, 464
(2017)
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebocontrolled trial
Robert Aiello, P. Bourassa, Saralyn Lindsey, Weifan Weng, Edward Natoli, B. Rollins, Patrice Milos (1999)
Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice.Arteriosclerosis, thrombosis, and vascular biology, 19 6
(2018)
Interleukin-1β has atheroprotective effects in advanced atherosclerotic lesions of mice
Saravana Ramasamy (2017)
Structure and Functions of Blood Vessels and Vascular Niches in BoneStem Cells International, 2017
Clinton Robbins, I. Hilgendorf, G. Weber, I. Theurl, Y. Iwamoto, Jose-Luiz Figueiredo, Rostic Gorbatov, G. Sukhova, Louisa Gerhardt, D. Smyth, Caleb Zavitz, E. Shikatani, M. Parsons, N. Rooijen, Herbert Lin, M. Husain, P. Libby, M. Nahrendorf, R. Weissleder, F. Swirski (2013)
Local proliferation dominates lesional macrophage accumulation in atherosclerosisNature medicine, 19
K. Stark, Annekathrin Eckart, Selgai Haidari, A. Tirniceriu, M. Lorenz, M. Brühl, Florian Gärtner, A. Khandoga, K. Legate, Robert Pless, I. Hepper, K. Lauber, B. Walzog, S. Massberg (2012)
Capillary and arteriolar pericytes attract innate leukocytes exiting through venules and 'instruct' them with pattern-recognition and motility programsNature Immunology, 14
L. Gu, Y. Okada, S. Clinton, C. Gerard, G. Sukhova, P. Libby, B. Rollins (1998)
Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice.Molecular cell, 2 2
D. Taub, P. Proost, W. Murphy, M. Anver, D. Longo, J. Damme, J. Oppenheim (1995)
Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes.The Journal of clinical investigation, 95 3
A. Orr, N. Hastings, B. Blackman, B. Wamhoff (2009)
Complex Regulation and Function of the Inflammatory Smooth Muscle Cell Phenotype in AtherosclerosisJournal of Vascular Research, 47
Brittany Durgin, O. Cherepanova, Delphine Gomez, T. Karaoli, G. Alencar, Joshua Butcher, Yu-Qing Zhou, M. Bendeck, B. Isakson, G. Owens, J. Connelly (2017)
Smooth muscle cell-specific deletion of Col15a1 unexpectedly leads to impaired development of advanced atherosclerotic lesions.American journal of physiology. Heart and circulatory physiology, 312 5
Huize Pan, Chenyi Xue, B. Auerbach, Jiaxin Fan, Alexander Bashore, Jian Cui, Dina Yang, Sarah Trignano, Wen Liu, Jianting Shi, Chinyere Ihuegbu, Erin Bush, Jeremy Worley, Lukas Vlahos, P. Laise, Robert Solomon, E. Connolly, A. Califano, P. Sims, Hanrui Zhang, Mingyao Li, M. Reilly (2020)
Single-Cell Genomics Reveals a Novel Cell State During Smooth Muscle Cell Phenotypic Switching and Potential Therapeutic Targets for Atherosclerosis in Mouse and HumanCirculation, 142
J. Miano, E. Fisher, M. Majesky (2021)
Fate and State of Vascular Smooth Muscle Cells in Atherosclerosis.Circulation, 143 21
G. Alencar, K. Owsiany, S. Karnewar, Katyayani Sukhavasi, G. Mocci, A. Nguyen, Corey Williams, Sohel Shamsuzzaman, M. Mokry, C. Henderson, Ryan Haskins, Richard Baylis, A. Finn, C. McNamara, Eli Zunder, Vamsidhar Venkata, G. Pasterkamp, J. Björkegren, S. Bekiranov, G. Owens (2020)
Stem Cell Pluripotency Genes Klf4 and Oct4 Regulate Complex SMC Phenotypic Changes Critical in Late-Stage Atherosclerotic Lesion PathogenesisCirculation, 142
Delphine Gomez, Laura Shankman, A. Nguyen, G. Owens (2012)
Detection of Histone Modifications at Specific Gene Loci in Single Cells in Histological SectionsNature methods, 10
T. Yoshimura, Carole Galligan, Munehisa Takahashi, Keqiang Chen, Mingyong Liu, L. Tessarollo, Ji Wang (2013)
Non-Myeloid Cells are Major Contributors to Innate Immune Responses via Production of Monocyte Chemoattractant Protein-1/CCL2Frontiers in Immunology, 4
Arun Kumar (2015)
Letter by Kumar regarding article, "contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis".Circulation
N. Serbina, E. Pamer (2006)
Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2Nature Immunology, 7
L. Fantuzzi, P. Borghi, Veniero Ciolli, G. Pavlakis, Filippo Belardelli, S. Gessani (1999)
Loss of CCR2 expression and functional response to monocyte chemotactic protein (MCP-1) during the differentiation of human monocytes: role of secreted MCP-1 in the regulation of the chemotactic response.Blood, 94 3
O. Cherepanova, Delphine Gomez, Laura Shankman, P. Swiatlowska, Jason Williams, Olga Sarmento, G. Alencar, Daniel Hess, Melissa Bevard, Elizabeth Greene, Meera Murgai, S. Turner, Y. Geng, S. Bekiranov, J. Connelly, A. Tomilin, G. Owens (2016)
Activation of the ESC pluripotency factor OCT4 in smooth muscle cells is atheroprotectiveNature medicine, 22
R. Toro, R. Chèvre, C. Rodríguez, A. Ordóñez, J. Martínez-González, V. Andrés, S. Méndez-Ferrer (2016)
Nestin+ cells direct inflammatory cell migration in atherosclerosisNature Communications, 7
C. McAlpine, M. Kiss, S. Rattik, Shun He, A. Vassalli, C. Valet, Atsushi Anzai, Christopher Chan, John Mindur, F. Kahles, W. Poller, V. Frodermann, A. Fenn, Annemijn Gregory, Lennard Halle, Y. Iwamoto, F. Hoyer, C. Binder, P. Libby, M. Tafti, T. Scammell, M. Nahrendorf, F. Swirski (2019)
Sleep modulates hematopoiesis and protects against atherosclerosisNature, 566
Yuyao Wang, Weili Zhang, S. Li, Weihua Song, Jing-zhou Chen, R. Hui (2011)
Genetic variants of the monocyte chemoattractant protein-1 gene and its receptor CCR2 and risk of coronary artery disease: a meta-analysis.Atherosclerosis, 219 1
S. Schwartz (2018)
Faculty Opinions recommendation of Corrigendum: KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis.Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
(2016)
Vascular stem/ progenitor cell migration induced by smooth muscle cell-derived chemokine ligand 1 contributes to neointima formation
Peggy Robinet, D. Milewicz, L. Cassis, N. Leeper, Hong Lu, Jonathan Smith (2018)
Consideration of Sex Differences in Design and Reporting of Experimental Arterial Pathology Studies-Statement From ATVB Council.Arteriosclerosis, thrombosis, and vascular biology, 38 2
J. Gilbert, J. Lekstrom-Himes, D. Donaldson, Yih Lee, Mingxiu Hu, Jing Xu, T. Wyant, M. Davidson (2011)
Effect of CC chemokine receptor 2 CCR2 blockade on serum C-reactive protein in individuals at atherosclerotic risk and with a single nucleotide polymorphism of the monocyte chemoattractant protein-1 promoter region.The American journal of cardiology, 107 6
S. Denger, L. Jahn, P. Wende, L. Watson, S. Gerber, W. Kübler, J. Kreuzer (1999)
Expression of monocyte chemoattractant protein-1 cDNA in vascular smooth muscle cells: induction of the synthetic phenotype: a possible clue to SMC differentiation in the process of atherogenesis.Atherosclerosis, 144 1
Background: Smooth muscle cells (SMCs) in atherosclerotic plaque take on multiple nonclassical phenotypes that may affect plaque stability and, therefore, the likelihood of myocardial infarction or stroke. However, the mechanisms by which these cells affect stability are only beginning to be explored. Methods: In this study, we investigated the contribution of inflammatory MCP1 (monocyte chemoattractant protein 1) produced by both classical Myh11 (myosin heavy chain 11)+ SMCs and SMCs that have transitioned through an Lgals3 (galectin 3)+ state in atherosclerosis using smooth muscle lineage tracing mice that label all Myh11+ cells and a dual lineage tracing system that targets Lgals3-transitioned SMC only. Results: We show that loss of MCP1 in all Myh11+ smooth muscle results in a paradoxical increase in plaque size and macrophage content, driven by a baseline systemic monocytosis early in atherosclerosis pathogenesis. In contrast, knockout of MCP1 in Lgals3-transitioned SMCs using a complex dual lineage tracing system resulted in lesions with an increased Acta2 (actin alpha 2, smooth muscle)+ fibrous cap and decreased investment of Lgals3-transitioned SMCs, consistent with increased plaque stability. Finally, using flow cytometry and single-cell RNA sequencing, we show that MCP1 produced by Lgals3-transitioned SMCs influences multiple populations of inflammatory cells in late-stage plaques. Conclusions: MCP1 produced by classical SMCs influences monocyte levels beginning early in disease and was atheroprotective, while MCP1 produced by the Lgals3-transitioned subset of SMCs exacerbated plaque pathogenesis in late-stage disease. Results are the first to determine the function of Lgals3-transitioned inflammatory SMCs in atherosclerosis and highlight the need for caution when considering therapeutic interventions involving MCP1.
Arteriosclerosis Thrombosis and Vascular Biology – Wolters Kluwer Health
Published: Aug 23, 2022
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.